Corcept Therapeutics, Inc. (CORT) Reports Q3 EPS Loss of $0.08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $81.12 --0%
Revenue Growth %: +56.0%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
LTBR, AES, SYRS, More
Revenue Growth %: +56.0%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
- Tower Semiconductor rises on strong Q4 revenue guidance
- Cipher Mining Inc. (CIFR) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
